Cargando…

A selenium species in cerebrospinal fluid predicts conversion to Alzheimer’s dementia in persons with mild cognitive impairment

BACKGROUND: Little is known about factors influencing progression from mild cognitive impairment to Alzheimer’s dementia. A potential role of environmental chemicals and specifically of selenium, a trace element of nutritional and toxicological relevance, has been suggested. Epidemiologic studies of...

Descripción completa

Detalles Bibliográficos
Autores principales: Vinceti, Marco, Chiari, Annalisa, Eichmüller, Marcel, Rothman, Kenneth J., Filippini, Tommaso, Malagoli, Carlotta, Weuve, Jennifer, Tondelli, Manuela, Zamboni, Giovanna, Nichelli, Paolo F., Michalke, Bernhard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5735937/
https://www.ncbi.nlm.nih.gov/pubmed/29258624
http://dx.doi.org/10.1186/s13195-017-0323-1
_version_ 1783287297930690560
author Vinceti, Marco
Chiari, Annalisa
Eichmüller, Marcel
Rothman, Kenneth J.
Filippini, Tommaso
Malagoli, Carlotta
Weuve, Jennifer
Tondelli, Manuela
Zamboni, Giovanna
Nichelli, Paolo F.
Michalke, Bernhard
author_facet Vinceti, Marco
Chiari, Annalisa
Eichmüller, Marcel
Rothman, Kenneth J.
Filippini, Tommaso
Malagoli, Carlotta
Weuve, Jennifer
Tondelli, Manuela
Zamboni, Giovanna
Nichelli, Paolo F.
Michalke, Bernhard
author_sort Vinceti, Marco
collection PubMed
description BACKGROUND: Little is known about factors influencing progression from mild cognitive impairment to Alzheimer’s dementia. A potential role of environmental chemicals and specifically of selenium, a trace element of nutritional and toxicological relevance, has been suggested. Epidemiologic studies of selenium are lacking, however, with the exception of a recent randomized trial based on an organic selenium form. METHODS: We determined concentrations of selenium species in cerebrospinal fluid sampled at diagnosis in 56 participants with mild cognitive impairment of nonvascular origin. We then investigated the relation of these concentrations to subsequent conversion from mild cognitive impairment to Alzheimer’s dementia. RESULTS: Twenty-one out of the 56 subjects developed Alzheimer’s dementia during a median follow-up of 42 months; four subjects developed frontotemporal dementia and two patients Lewy body dementia. In a Cox proportional hazards model adjusting for age, sex, duration of sample storage, and education, an inorganic selenium form, selenate, showed a strong association with Alzheimer’s dementia risk, with an adjusted hazard ratio of 3.1 (95% confidence interval 1.0–9.5) in subjects having a cerebrospinal fluid content above the median level, compared with those with lower concentration. The hazard ratio of Alzheimer’s dementia showed little departure from unity for all other inorganic and organic selenium species. These associations were similar in analyses that measured exposure on a continuous scale, and also after excluding individuals who converted to Alzheimer’s dementia at the beginning of the follow-up. CONCLUSIONS: These results indicate that higher amounts of a potentially toxic inorganic selenium form in cerebrospinal fluid may predict conversion from mild cognitive impairment to Alzheimer’s dementia. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13195-017-0323-1) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5735937
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-57359372017-12-21 A selenium species in cerebrospinal fluid predicts conversion to Alzheimer’s dementia in persons with mild cognitive impairment Vinceti, Marco Chiari, Annalisa Eichmüller, Marcel Rothman, Kenneth J. Filippini, Tommaso Malagoli, Carlotta Weuve, Jennifer Tondelli, Manuela Zamboni, Giovanna Nichelli, Paolo F. Michalke, Bernhard Alzheimers Res Ther Research BACKGROUND: Little is known about factors influencing progression from mild cognitive impairment to Alzheimer’s dementia. A potential role of environmental chemicals and specifically of selenium, a trace element of nutritional and toxicological relevance, has been suggested. Epidemiologic studies of selenium are lacking, however, with the exception of a recent randomized trial based on an organic selenium form. METHODS: We determined concentrations of selenium species in cerebrospinal fluid sampled at diagnosis in 56 participants with mild cognitive impairment of nonvascular origin. We then investigated the relation of these concentrations to subsequent conversion from mild cognitive impairment to Alzheimer’s dementia. RESULTS: Twenty-one out of the 56 subjects developed Alzheimer’s dementia during a median follow-up of 42 months; four subjects developed frontotemporal dementia and two patients Lewy body dementia. In a Cox proportional hazards model adjusting for age, sex, duration of sample storage, and education, an inorganic selenium form, selenate, showed a strong association with Alzheimer’s dementia risk, with an adjusted hazard ratio of 3.1 (95% confidence interval 1.0–9.5) in subjects having a cerebrospinal fluid content above the median level, compared with those with lower concentration. The hazard ratio of Alzheimer’s dementia showed little departure from unity for all other inorganic and organic selenium species. These associations were similar in analyses that measured exposure on a continuous scale, and also after excluding individuals who converted to Alzheimer’s dementia at the beginning of the follow-up. CONCLUSIONS: These results indicate that higher amounts of a potentially toxic inorganic selenium form in cerebrospinal fluid may predict conversion from mild cognitive impairment to Alzheimer’s dementia. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13195-017-0323-1) contains supplementary material, which is available to authorized users. BioMed Central 2017-12-19 /pmc/articles/PMC5735937/ /pubmed/29258624 http://dx.doi.org/10.1186/s13195-017-0323-1 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Vinceti, Marco
Chiari, Annalisa
Eichmüller, Marcel
Rothman, Kenneth J.
Filippini, Tommaso
Malagoli, Carlotta
Weuve, Jennifer
Tondelli, Manuela
Zamboni, Giovanna
Nichelli, Paolo F.
Michalke, Bernhard
A selenium species in cerebrospinal fluid predicts conversion to Alzheimer’s dementia in persons with mild cognitive impairment
title A selenium species in cerebrospinal fluid predicts conversion to Alzheimer’s dementia in persons with mild cognitive impairment
title_full A selenium species in cerebrospinal fluid predicts conversion to Alzheimer’s dementia in persons with mild cognitive impairment
title_fullStr A selenium species in cerebrospinal fluid predicts conversion to Alzheimer’s dementia in persons with mild cognitive impairment
title_full_unstemmed A selenium species in cerebrospinal fluid predicts conversion to Alzheimer’s dementia in persons with mild cognitive impairment
title_short A selenium species in cerebrospinal fluid predicts conversion to Alzheimer’s dementia in persons with mild cognitive impairment
title_sort selenium species in cerebrospinal fluid predicts conversion to alzheimer’s dementia in persons with mild cognitive impairment
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5735937/
https://www.ncbi.nlm.nih.gov/pubmed/29258624
http://dx.doi.org/10.1186/s13195-017-0323-1
work_keys_str_mv AT vincetimarco aseleniumspeciesincerebrospinalfluidpredictsconversiontoalzheimersdementiainpersonswithmildcognitiveimpairment
AT chiariannalisa aseleniumspeciesincerebrospinalfluidpredictsconversiontoalzheimersdementiainpersonswithmildcognitiveimpairment
AT eichmullermarcel aseleniumspeciesincerebrospinalfluidpredictsconversiontoalzheimersdementiainpersonswithmildcognitiveimpairment
AT rothmankennethj aseleniumspeciesincerebrospinalfluidpredictsconversiontoalzheimersdementiainpersonswithmildcognitiveimpairment
AT filippinitommaso aseleniumspeciesincerebrospinalfluidpredictsconversiontoalzheimersdementiainpersonswithmildcognitiveimpairment
AT malagolicarlotta aseleniumspeciesincerebrospinalfluidpredictsconversiontoalzheimersdementiainpersonswithmildcognitiveimpairment
AT weuvejennifer aseleniumspeciesincerebrospinalfluidpredictsconversiontoalzheimersdementiainpersonswithmildcognitiveimpairment
AT tondellimanuela aseleniumspeciesincerebrospinalfluidpredictsconversiontoalzheimersdementiainpersonswithmildcognitiveimpairment
AT zambonigiovanna aseleniumspeciesincerebrospinalfluidpredictsconversiontoalzheimersdementiainpersonswithmildcognitiveimpairment
AT nichellipaolof aseleniumspeciesincerebrospinalfluidpredictsconversiontoalzheimersdementiainpersonswithmildcognitiveimpairment
AT michalkebernhard aseleniumspeciesincerebrospinalfluidpredictsconversiontoalzheimersdementiainpersonswithmildcognitiveimpairment
AT vincetimarco seleniumspeciesincerebrospinalfluidpredictsconversiontoalzheimersdementiainpersonswithmildcognitiveimpairment
AT chiariannalisa seleniumspeciesincerebrospinalfluidpredictsconversiontoalzheimersdementiainpersonswithmildcognitiveimpairment
AT eichmullermarcel seleniumspeciesincerebrospinalfluidpredictsconversiontoalzheimersdementiainpersonswithmildcognitiveimpairment
AT rothmankennethj seleniumspeciesincerebrospinalfluidpredictsconversiontoalzheimersdementiainpersonswithmildcognitiveimpairment
AT filippinitommaso seleniumspeciesincerebrospinalfluidpredictsconversiontoalzheimersdementiainpersonswithmildcognitiveimpairment
AT malagolicarlotta seleniumspeciesincerebrospinalfluidpredictsconversiontoalzheimersdementiainpersonswithmildcognitiveimpairment
AT weuvejennifer seleniumspeciesincerebrospinalfluidpredictsconversiontoalzheimersdementiainpersonswithmildcognitiveimpairment
AT tondellimanuela seleniumspeciesincerebrospinalfluidpredictsconversiontoalzheimersdementiainpersonswithmildcognitiveimpairment
AT zambonigiovanna seleniumspeciesincerebrospinalfluidpredictsconversiontoalzheimersdementiainpersonswithmildcognitiveimpairment
AT nichellipaolof seleniumspeciesincerebrospinalfluidpredictsconversiontoalzheimersdementiainpersonswithmildcognitiveimpairment
AT michalkebernhard seleniumspeciesincerebrospinalfluidpredictsconversiontoalzheimersdementiainpersonswithmildcognitiveimpairment